| 1 | CRSP | CRISPR Therapeutics AG | 9.18% |
| 2 | TWST | Twist Bioscience Corporation | 8.87% |
| 3 | TEM | Tempus AI, Inc. | 8.74% |
| 4 | TXG | 10x Genomics, Inc. | 6.04% |
| 5 | PSNL | Personalis, Inc. | 5.37% |
| 6 | BEAM | Beam Therapeutics Inc. | 4.80% |
| 7 | ILMN | Illumina, Inc. | 4.47% |
| 8 | NTRA | Natera, Inc. | 4.37% |
| 9 | GH | Guardant Health, Inc. | 4.00% |
| 10 | NTLA | Intellia Therapeutics, Inc. | 3.68% |
| 11 | RXRX | Recursion Pharmaceuticals, Inc. | 3.62% |
| 12 | CDNA | CareDx, Inc. | 3.57% |
| 13 | VCYT | Veracyte, Inc. | 3.25% |
| 14 | ABSI | Absci Corporation | 3.13% |
| 15 | ADPT | Adaptive Biotechnologies Corporation | 2.71% |
| 16 | NRIX | Nurix Therapeutics, Inc. | 2.45% |
| 17 | SDGR | Schrödinger, Inc. | 2.21% |
| 18 | WGS | GeneDx Holdings Corp. | 2.01% |
| 19 | BFLY | Butterfly Network, Inc. | 1.99% |
| 20 | IONS | Ionis Pharmaceuticals, Inc. | 1.96% |
| 21 | ARCT | Arcturus Therapeutics Holdings Inc. | 1.77% |
| 22 | CMPS | COMPASS Pathways plc | 1.71% |
| 23 | PRME | Prime Medicine, Inc. | 1.64% |
| 24 | ATAI | AtaiBeckley Inc. | 1.42% |
| 25 | PACB | Pacific Biosciences of California, Inc. | 1.36% |
| View ARKG holdings |
